Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000579 · ClinicalTrials.gov registry record · Phase 3
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
A Phase 3 study, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- Completed
- Registry status
- Phase 3
- Development phase
NCT00000579: Completed Phase 3 study, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
NCT00000579 is a Phase 3 study that has completed, run by National Heart, Lung, and Blood Institute (NHLBI). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00000579, a Phase 3 study, has completed, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- COMPLETED
- Registry status
- Phase 3
- Development phase
Study Summary
The purposes of this study are to assess rapidly innovative treatment methods in patients with adult respiratory distress syndrome (ARDS) as well as those at risk of developing ARDS and to create a network of interactive Critical Care Treatment Groups (CCTGs) to establish and maintain the required infrastructure to perform multiple therapeutic trials that may involve investigational drugs, approved agents not currently used for treatment of ARDS, or treatments currently used but whose efficacy has not been well documented.
Interventions
- DRUG Methylprednisolone
- DRUG Ketoconazole
- PROCEDURE Low Tidal Volume Ventilation
- PROCEDURE Positive End-Expiratory Pressure
- DRUG Lysofylline
Trial Details
| Field | Value |
|---|---|
| Start Date | 1994-09 |
| Est. Completion | 2004-07 |
| Phase | Phase 3 |
What the finished NCT00000579 record still lists
NCT00000579 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 5 interventions - of which Methylprednisolone is the first listed.
NCT00000579 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00000579 about?
NCT00000579 is a clinical study titled "Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)". The purposes of this study are to assess rapidly innovative treatment methods in patients with adult respiratory distress syndrome (ARDS) as well as those at risk of developing ARDS and to create a network of interactive Critical Care Treatment Groups (CCTGs) to establish and maintain the required i...
What is the current status of trial NCT00000579?
This trial is currently completed. It is a Phase 3 study. The study started on 1994-09. Estimated completion is 2004-07.
What interventions are being tested in trial NCT00000579?
The interventions under investigation include: Methylprednisolone (DRUG), Ketoconazole (DRUG), Low Tidal Volume Ventilation (PROCEDURE), Positive End-Expiratory Pressure (PROCEDURE), Lysofylline (DRUG).
Who is sponsoring clinical trial NCT00000579?
This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia